Recent Headlines
Within Pharmaceuticals
CoreRx, Inc. Announces New Expanded Capabilities
CoreRx, Inc. is an American owned company located in Tampa, Florida. CoreRx, Inc. announces the expansion of it’s capabilities including DEA licensure for controlled substances. This gives CoreRx, Inc. the ability to work with DEA schedule 2-5 active pharmaceutical ingredients and drug... - May 12, 2007 - CoreRx, Inc.
Futuristic Sleep Machine Now Reality
Those seeking improved sleep can switch on Sleep on Command™ device designed to enforce Delta rhythm sleep and the recovery that best occurs during deep, slow-wave, Delta-stage sleep. - May 08, 2007 - EarthPulse Tech, LLC
Age Defying Collagen Capsule Made in NZ
Puraz Health’s product - 100% Collagen, contains pure collagen and is manufactured in New Zealand. The unique design of the capsules means that collagen can be distributed to where it may have depleted: to joints, ligaments and to the biggest organ, the skin. This means that collagen, in the past only available to plastic surgeons, is now available to the whole body in natural capsule form. - May 08, 2007 - Puraz Health
Baxa Corporation Signs Co-Marketing Agreement with CriticalPoint for Interactive Web-Based Training
Baxa Corporation announces its agreement with CriticalPoint LLC to co-market a Web-based sterile compounding curriculum authored by internationally recognized subject matter experts. This comprehensive, ACPE-approved program consists of 32 modules that meet USP Chapter 797’s competency assessment requirements. Modules are self-paced and part of CriticalPoint’s Learning Management System (LMS), offering access from any Web connection and providing administrative reporting for tracking. - May 07, 2007 - Baxa Corporation
2007-08 Bioscience Colorado Magazine Debuts at BIO International Convention in Boston
Colorado Bioscience Association is releasing the new edition of Bioscience Colorado Magazine at the 2007 BIO International Convention, May 6-9, at the Boston Convention & Exhibition Center. This year’s magazine has expanded to 80 pages and includes an updated directory of the Colorado Bioscience industry: Medical Device and Related Companies; Biotechnology, Pharmaceutical and Related Companies; Biofuels and Related Companies; Research & Education Institutions; Foundations; & Service Providers. - May 06, 2007 - Colorado BioScience Association
New Research Presented by MD Anderson and University of Utah Verifies Dry Connections with PhaSeal
New evidence-based research was presented at ONS Congress by MD Anderson and the University of Utah which concluded only the PhaSeal System confined the drug, thus proving the prevention of drug exposure from preparation through administration of hazardous drugs. - May 05, 2007 - Carmel Pharma
“Premature Infants Safer Because Of New Feeding System,” Case Study Now Accessible at PublicRelationsNewsroom.com
“Premature Infants Safer Because Of New Feeding System,” a case study from Premier, Inc., and its member hospitals, in collaboration with Baxa Corporation and VIASYS MedSystems, is now accessible at PublicRelationsNewsroom.com. According to the case, thanks to the collaboration, tiny infants receiving nutrition through feeding tubes now face far less danger from the risk of IV lines and feeding tubes being accidentally connected. - May 03, 2007 - Baxa Corporation
Carmel Pharma, Inc. Launches New PhaSeal Preparation Component
Carmel Pharma, Inc. launches their new Protector 28 (P28). This preparation component is the latest advancement of the PhaSeal System and is available now. - May 03, 2007 - Carmel Pharma
Training Makes a Difference: New Study Finds Farmer Production Costs Decreased, Farmer and Food Safety Increased
Farmers were able to reduce their costs of production, while more effectively controlling pests and better protecting themselves and their farms – all thanks to a practical training programme with farmers in rural China. “Responsible use of crop protection products increases food... - May 01, 2007 - CropLife Asia
Baxa Corporation Announces Enteral Syringes Now on Contract with AmeriNet, MedAssets, Novation and Premier Group Purchasing Organizations
Baxa Corporation announces its new syringes, designed for enteral feeding only, have been accepted on contract with key group purchasing organizations to facilitate hospital compliance with patient safety goals and to prevent wrong-route errors. Contracts for enteral syringes have been made between Baxa and these top US group purchasing organizations: AmeriNet, MedAssets, Novation and Premier. - April 30, 2007 - Baxa Corporation
Artificial Sun for Cell Culture Heating
The LAMBDA MINIFOR fermenter / bioreactor provides a new heating system for precise, fast and economic heating of the culture medium in fermentation and cell culture processes - April 29, 2007 - LAMBDA Laboratory Instruments
Personalized Lab Services, LLC Offers New, Next-Day HIV-1 Test with +99.9% Proven Accuracy
Personalized Lab Services, LLC that distributes the only U.S. Food and Drug Administration (FDA)-approved at-home HIV-1 test, announced today that it has begun providing next business day results for its Express HIV-1 Test System. The accelerated, next business-day results continue to provide the... - April 28, 2007 - Personalized Lab Services, LLC
MenScience Tackles Men's Heart Health with the Omega 3 Supplement Formula
Because of the many benefits displayed by Omega-3 in its role in men’s cardiovascular health, MenScience has created the Omega 3 Supplement Formula. Its pharmaceutical-grade formula incorporates a high dose (1500 mg) of Omega-3 fatty acids to help protect men’s cardiovascular health, promote healthy brain function and mood levels, and increase joint and muscle mobility. - April 26, 2007 - MenScience Androceuticals
Carmel Pharma Offers New Continuing Education Program
Carmel Pharma, manufacturers and distributors of PhaSeal, announced today that they are now offering an accredited continuing education (CE) program developed by STAT Educational Services, an accredited provider of continuing education for various healthcare professionals. - April 25, 2007 - Carmel Pharma
New Medical Breakthrough: FDA Approved Device Can Turn Deadly Oral Cancer Into Treatable Cancer
A new breakthrough technology sets new oral tissue screening standards, enabling cancerous lesions to be diagnosed that may be undetectable under regular overhead white dental lights. The new device, VELscope, uses blue excitation light and a specialized filter to help dental professionals screen... - April 24, 2007 - Dentistry For Health New York, PLLC
Baxa Corporation Features Pharmacy Automation and Dedicated Oral Dispensers at the Interphex 2007 Exhibition
Baxa Corporation is promoting its industry-leading products for automating pharmacy filling operations and safe dispensing of oral liquid medications at the annual Interphex Conference and Exhibition beginning today at the Jacob K. Javits Convention Center in New York City. The annual Interphex Conference brings together global companies serving the pharmaceutical and biotechnical industries. - April 24, 2007 - Baxa Corporation
Interleukin & Chemokine Antibodies – Two Types of Cytokine Antibodies
Interleukin-32 (IL-32), whose expression is increased following activation by IL-2, was initially identified as a transcript (NK4) selectively expressed in lymphocytes and NK cells.1 - April 18, 2007 - AnaSpec, EGT Group
Baxa Praises the UK’s NPSA Patient Safety Alert Advising Hospitals to Switch to Safer Oral/Enteral Syringes
The UK’s National Patient Safety Agency (NPSA) has released a Patient Safety Alert detailing the hazards of wrong-route administration and recommending immediate actions to ensure that oral/enteral medications cannot be administered through an intravenous connection. Hospitals can comply with the Patient Safety Alert immediately using the Exacta-Med® Oral/Enteral Dispensers from Baxa Ltd, Baxa Corporation’s UK subsidiary. - April 17, 2007 - Baxa Corporation
New Drug and Alcohol Testing Services from Medimpex United Inc.
Starting from middle of April, 2007 Medimpex United, Inc. (www.meditests.com) open new services and upgrade existing ones for all your drug and alcohol testing needs. 1. Medimpex United, Inc. start to provides MRO (Medical Review Officer) Service for the urine laboratory drug test confirmation 2. Also they're open the Urine Alcohol traces detection up to 80 hours after alcohol intakes 3. Laboratory GC/MS Urine Drug Test Confirmation available for up to 12 illegal drugs with new low price - April 13, 2007 - Medimpex United Inc
DDL Adds Package Design, Development & Prototyping to Service Offerings
Increased Demand for Package, Product & Material Testing Brings Further Expansion for Testing Services Firm. - April 13, 2007 - DDL Inc.
ABRF Poster Presents Comparison of Fluorescent Peptide Synthesis Methods
At the 2007 annual conference of the Association of Biomolecular Resource Facilities, AnaSpec presented a technical poster that compared the synthesis of a fluorescent peptide using two types of resins. The results of the poster indicated that the use of an unprotected resin was just as effective... - April 13, 2007 - AnaSpec, EGT Group
New Technology to Study the Mechanism of Cancer
Switchgear Genomics unveils new experimental technology to characterize the biological networks of cancer cells. - April 12, 2007 - SwitchGear Genomics
MSLs Learn About Best Practices in the Art of Medical Science Liaising
Medical Science Liaison University's Medical Science Liaison Success Practicum May 10-11, 2007 - April 11, 2007 - Medical Science Liaison Institute
New Dye Solution for Far Red to NIR Imaging
Utilizing its proprietary HiLyte Fluor™ technology, AnaSpec has introduced dye solutions for far red to NIR imaging. AnaSpec’s HiLyte Fluor™ 647, HiLyte Fluor™ 680, and HiLyte Fluor™ 750 provide AnaSpec with a range of dyes that cover the spectrum. AnaSpec has also... - April 11, 2007 - AnaSpec, EGT Group
New Instant On-the-Spot Employee Drug Test
99.9% Accurate, FDA Cleared, Simple Mouth and Gum Swab Test - April 05, 2007 - Personalized Lab Services, LLC
AnaSpec Introduces AnaTag™ Protein Labeling Kits
The labeling of proteins and antibodies with fluorescent dyes can play a crucial role in flow cytometry, immunohistochemistry and fluorescent in-situ hybridization techniques. Incorporating its high performance HiLyte Fluor™ dyes in a ready-to-use kit, AnaSpec has introduce its new line of... - April 04, 2007 - AnaSpec, EGT Group
RTC Introduces a New Line
RTC Introduces a New Line of Secondary/Working Pharmaceutical Reference Standards to Meet the Needs of Labs Working in an ISO 17025 Environment - April 04, 2007 - RTC
New Evidence-based Research will be Unveiled During 'Ask the Experts’ at ONS Congress in April
New evidence-based research for determining adherence to the NIOSH definition of a closed-system will be unveiled during ‘Ask the Experts’ at the ONS Congress on Wednesday, April 25 in Las Vegas, NV. ‘Ask the Experts’ will be held from 1pm-2pm on Wednesday, April 25 in the... - April 04, 2007 - Carmel Pharma
Colorado Bioscience Association Launches Colorado Springs Chapter
The debut of the Colorado Springs Chapter of the Colorado Bioscience Association (CBSA) occurred yesterday at the University of Colorado at Colorado Springs (UCCS). The announcement is made by Denise Brown, CBSA Executive Director, who says UCCS Chancellor Pam Shockley hosted the chapter launch event. - March 29, 2007 - Colorado BioScience Association
Dr. Robert Pastore Re-launches Nutritional Supplements Line with New Website
Pastore Formulations announces new site to showcase its expanding line of high end supplements. - March 28, 2007 - Pastore Formulations
The Only Test that Takes the Guesswork out of what Vitamins and Supplements your Body Needs
Why You May Need An Intracellular Vitamin Analysis - March 28, 2007 - Personalized Lab Services, LLC
AnaSpec Launches Optimized Website
In an effort to optimize the online experience of its customers, AnaSpec, a worldwide provider of integrated proteomics solutions, has moved its website to a faster, dedicated server. AnaSpec sales & marketing manager, Violeta Rajkovska, MBA, stated, “With the huge number of catalog... - March 28, 2007 - AnaSpec, EGT Group
Take the Guesswork Out of Choosing the Right Combination of Vitamins and Supplements
With the increasing popularity of vitamins and supplements, today's consumer now has more choices than ever before, and sometimes that means more confusion. To cut through the clutter, Puritan's Pride has created special vitamin and supplement package deals bundled together for specific age... - March 24, 2007 - Puritan's Pride
Baxa Corporation Launches Educational Campaign Highlighting the Risks of Enteral Tubing Misconnections
Campaign for Baxa dedicated enteral systems focuses on educating providers on the risks, especially for neonatal patients, of wrong-route administration of non-IV fluids. While tubing misconnections can be deadly for any patient, neonates represent the highest risk population due to their small size and other health complications. The campaign launch closely follows the January 2007 release by the Joint Commission of their proposed 2008 National Patient Safety Goals (NPSGs) for comment. - March 21, 2007 - Baxa Corporation
Transcutaneous Bioelectric Stimulation - the Problem of Penetration and Propagation
In the past few years, there has been a resurgence of interest in bio-electrical therapies in the medical community. In some areas however, there has been a proliferation of research resulting in numerous clinical applications directed at patient care. Many health care facilities are successfully... - March 17, 2007 - Technical AP
Two Leading Biotech Publications Report on Advaxis’ Listeria Platform Technology
Advaxis’ John Rothman Recognized as one of 20 Notable People in R&D - March 16, 2007 - Advaxis
Bio3 Research S.r.l., Milan – Italy, Has Been Granted by the Australian Patent Office a Patent in the Field of HMGB1
Bio3 Research S.r.l., Milan – Italy, has been granted by the Australian Patent Office a patent in the field of cardiovascular diseases related to HMGB1 over-expression and for the use of HMGB1 protein in connective tissue regeneration. - March 16, 2007 - Bio3 Research S.r.l.
Two Colorado Bioscience Legislative Initiatives Rank Among BIO’s Best Practices in the Nation
Two Colorado bioscience legislative initiatives are included in the national BIO “State Legislative Best Practices in Support of Bioscience Industry Development,” report issued late last year for state legislation promoting growth of bioscience clusters in 2005-06. Of the 23 standout initiatives, only two other states, California and Texas, had two projects highlighted. - March 14, 2007 - Colorado BioScience Association
Name Change: AnaSpec’s EnzoLyte is now SensoLyte™
AnaSpec, a worldwide provider of integrated proteomics solutions, announced today that the name of their flagship line of high-performance assay kits has been changed from EnzoLyte to SensoLyte™. AnaSpec sales & marketing manager, Violeta Rajkovska, MBA, noted, “The new name... - March 14, 2007 - AnaSpec, EGT Group
Xcelience Employs "CFS1200 Capsule Filling and Sealing Machine"
Xcelience's implementation of the CFS1200 will allow its formulation scientists the opportunity to accelerate the drug development timeframe. - March 13, 2007 - Xcelience, LLC
Actor Cheryl Hines is Tired of Counting Sheep to Sleep... And is Painting Them Instead
In insomnia news, actor and insomnia sufferer, Cheryl Hines, joins the American Academy of Nurse Practitioners (AANP) Foundation to pull the covers off chronic insomnia. “Why Count on Sheep to Sleep?”, an educational initiative, supported by Sanofi-Aventis, raises awareness of sleep problems, causes of insomnia, and provides people with sleep solutions. Sleep disorders can be a serious medical condition characterized by difficulty falling asleep and staying asleep. - March 10, 2007 - Sanofi-Aventis
Pro-Tect, Inc. (PRTT.PK) Acquires License to Mitigator® Brand Products
Pro-Tect, Inc. (PRTT.PK) announced today that it has entered into a licensing agreement with American Natural Technology Sciences (ANTS) for the marketing rights to Mitigator's® technology. - March 09, 2007 - Pro-Tect, Inc.
Xcelience Completes Successful QP Audit of Production Facility for European Market
Xcelience achives its third successful audit. - March 09, 2007 - Xcelience, LLC
Rayner Institute for Career Advancement Announces Its Sponsorship of the Development of New Think Tank, The Medical Esthetic Policy Network & Patient Advocacy Group
Sponsoring phase one of development of a non-profit endeavor and to encourage participation, the Rayner Institute has made the initial effort to temporarily host the first Web-based international Medical Esthetic Think Tank. The Medical Esthetic Policy Network & Patient Advocacy Group will... - March 08, 2007 - Rayner Institute For Career Development
UK Paternity Testing Centre Unveils New Online Resource
DNA Diagnostics Centre (DDC), a leading international DNA testing laboratory, recently launched its website in the UK, www.dnacentre.co.uk. The website serves as a useful resource for clients in the UK and Europe who require DNA testing services, such as paternity testing for immigration or child support. - March 08, 2007 - DNA Diagnostics Center
IndustryWeek Best Plants Conference Includes Datacraft Solutions
Datacraft Solutions is presenting at the IndustryWeek 2007 Best Plants Conference in Indianapolis, IN on April 24-25. The conference will include discussions of proven strategies, best practices and tools from the IW Best Plants past year‘s winners and nearly fifty other... - March 08, 2007 - Datacraft Solutions
The New Class of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Has One Clear Leader and Many Followers
Merck & Co clearly leads the field of DPP-IV inhibitors which has many followers in clinical development. The first companies already abandoned the field. - March 05, 2007 - La Merie Business Intelligence
Four Colorado Companies Participate at the 2007 Rocky Mountain Bioscience Venture Capital Meeting on the Mountain in Park City, Utah
Four Colorado-based companies are participating at the 2007 Rocky Mountain Bioscience Venture Capital Meeting on the Mountain, March 2-4, at the Park City (UT) Marriott. Dorsey & Whitney, lead sponsor of the event, hosts venture capitalists and area companies to learn and explore bioscience opportunities in the Rocky Mountain Region. Co-sponsors include UV Partners, vSpring Capital and Wasatch Venture Fund. - March 04, 2007 - Colorado BioScience Association
OmniActive Commissions New Plant in Pune, India to Export Patent Protected Products
OmniActive Health Technologies, a part of the Rs.600crore JV Mariwala group commissioned a new natural API (Active Pharmaceutical Intermediate) plant at the International Bio-Tech Park, Hinjewadi in Pune today. Responding to the rapid growth of business out of its facilities in Cochin and Thane,... - March 02, 2007 - OmniActive Health Technologies Pvt Ltd
Xcelience Debuts its Innovative and Interactive Forum: XpertXchange™
XpertXchange will initiate dialogue between Xcelience scientists and drug development professionals. - March 02, 2007 - Xcelience, LLC